🇩🇪 Germany Country × Condition
coronary artery disease Clinical Trials in Germany
Active clinical trials for coronary artery disease with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇩🇪 Germany
Active Trials in Germany (5)
NCT04196712
Recruiting
Essen Coronary Artery Disease Registry
Enrollment
55,000 pts
Country
🇩🇪 Germany
University Hospital, Essen
View Trial → NCT07091682
Recruiting
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions
Enrollment
100 pts
Country
🇩🇪 Germany
Biotronik AG
View Trial → NCT04011527
Recruiting
The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s
Enrollment
1,500 pts
Country
🇩🇪 Germany
Segeberger Kliniken GmbH
View Trial → NCT07016477
Recruiting
Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure
Enrollment
1,000 pts
Country
🇩🇪 Germany
Semmelweis University
View Trial → NCT04761068
Recruiting
Clinical Outcomes of Patients Undergoing CABG Surgery With VEST Supported Venous Grafts
Enrollment
1,000 pts
Country
🇩🇪 Germany
Cardiocentro Ticino
View Trial → Frequently Asked Questions
How many coronary artery disease clinical trials are active in Germany?
There are currently 5 active clinical trials for coronary artery disease with sites in Germany, of which 5 are actively recruiting patients.
How can I join a coronary artery disease clinical trial in Germany?
To join a coronary artery disease clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are coronary artery disease trials in Germany?
Active coronary artery disease trials in Germany span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.